Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression

[1]  Patrick Nicolas,et al.  Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. , 2004, Cancer research.

[2]  K. Chayama,et al.  Expression of VEGF‐C and VEGF‐D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma , 2004, Cancer science.

[3]  M. Tonato,et al.  Evaluation of the Prognostic Role of Vascular Endothelial Growth Factor and Microvessel Density in Stages I and II Breast Cancer Patients , 2003, Breast Cancer Research and Treatment.

[4]  J. Tille,et al.  Lymphangiogenesis and tumour metastasis. , 2004, Novartis Foundation symposium.

[5]  G. Gasparini,et al.  Clinical significance of angiogenic factors in breast cancer , 2004, Breast Cancer Research and Treatment.

[6]  S. Tsutsui,et al.  Prognostic value of microvessel density in invasive ductal carcinoma of the breast , 2003, Breast cancer.

[7]  J. Pammer,et al.  CD9 Expression on Lymphatic Vessels in Head and Neck Mucosa , 2003, Modern Pathology.

[8]  J. Tille,et al.  Lymphangiogenesis and tumor metastasis , 2003, Thrombosis and Haemostasis.

[9]  S. Nathanson,et al.  Insights into the mechanisms of lymph node metastasis , 2003, Cancer.

[10]  A. Harris,et al.  Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer , 2003, The Journal of pathology.

[11]  S. Groshen,et al.  Computerized Quantification of Tissue Vascularization Using High-resolution Slide Scanning of Whole Tumor Sections , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  P. Argani,et al.  Performance Characteristics of a Reverse Transcriptase–Polymerase Chain Reaction Assay for the Detection of Tumor-specific Fusion Transcripts from Archival Tissue , 2003, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[13]  Maria Chosia,et al.  Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma. , 2003, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[14]  K. Okita,et al.  Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis. , 2003, International journal of molecular medicine.

[15]  L. Belghiti,et al.  Prognostic factors in breast cancer , 2002 .

[16]  P. Isaacson,et al.  Archival Fixed Histologic and Cytologic Specimens Including Stained and Unstained Materials Are Amenable to RT-PCR , 2002, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[17]  J. Nährig,et al.  Quantification of CK20 gene and protein expression in colorectal cancer by RT‐PCR and immunohistochemistry reveals inter‐ and intratumour heterogeneity , 2002, The Journal of pathology.

[18]  Alexander Marks,et al.  A New Monoclonal Antibody, D2-40, for Detection of Lymphatic Invasion in Primary Tumors , 2002, Laboratory Investigation.

[19]  K. Alitalo,et al.  Metastasis: Lymphangiogenesis and cancer metastasis , 2002, Nature Reviews Cancer.

[20]  K. Alitalo,et al.  Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. , 2002, Investigative ophthalmology & visual science.

[21]  M. Pegram,et al.  Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor. , 2002, Seminars in oncology.

[22]  G. Jayson,et al.  Intra-tumoural microvessel density in human solid tumours , 2002, British Journal of Cancer.

[23]  K. Alitalo,et al.  VEGF‐C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF‐7 tumors , 2002, International journal of cancer.

[24]  Alexander Marks,et al.  Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas , 2002, Modern Pathology.

[25]  P. Hewett,et al.  Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. , 2002, Cancer research.

[26]  G. Vrensen,et al.  VEGFR‐3 in adult angiogenesis , 2001, The Journal of pathology.

[27]  K. Chayama,et al.  Clinicopathological significance of vascular endothelial growth factor (VEGF)‐C in human esophageal squamous cell carcinomas , 2001, International journal of cancer.

[28]  S. Breiteneder-Geleff,et al.  Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. , 2001, Anticancer research.

[29]  H. Höfler,et al.  Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. , 2001, The American journal of pathology.

[30]  Thomas Hawighorst,et al.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.

[31]  Steven A. Stacker,et al.  VEGF-D promotes the metastatic spread of tumor cells via the lymphatics , 2001, Nature Medicine.

[32]  Y. Nodasaka,et al.  Desmoplakin as a specific marker of lymphatic vessels. , 2001, Microvascular research.

[33]  Y. Tokeshi,et al.  The Relationship Between Microvessel Density, the Expression of Vascular Endothelial Growth Factor (VEGF), and the Extension of Nasopharyngeal Carcinoma , 2000, The Laryngoscope.

[34]  S. Edge,et al.  Prognostic factors in breast cancer , 2005 .

[35]  S. Hirohashi,et al.  Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  A. Folpe,et al.  Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of Angiosarcomas , 2000, Modern Pathology.

[37]  K. Alitalo,et al.  Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors , 1999, Cancer.

[38]  G. Oliver,et al.  Prox1 Function Is Required for the Development of the Murine Lymphatic System , 1999, Cell.

[39]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[40]  J. Primrose,et al.  Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. , 1999, Nucleic acids research.

[41]  E. Tschachler,et al.  Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. , 1999, The American journal of pathology.

[42]  M. Mildner,et al.  Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[43]  K. Alitalo,et al.  Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. , 1998, The American journal of pathology.

[44]  K Vajda,et al.  [Prognostic factors in breast cancer]. , 1998, Orvosi hetilap.

[45]  E. Tschachler,et al.  Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. , 1998, Cancer research.

[46]  J. Folkman,et al.  Angiogenesis and angiogenesis inhibition: an overview. , 1997, EXS.

[47]  H. Heinzl,et al.  Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods. , 1996, American journal of clinical pathology.

[48]  S. Fox,et al.  Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. , 1995, Journal of the National Cancer Institute.

[49]  A. Harris,et al.  Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis , 1995, The Journal of pathology.

[50]  Claudio Eccher,et al.  Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs. a computer-aided image analysis system , 1995 .

[51]  K. Chew,et al.  Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. , 1995, Journal of the National Cancer Institute.

[52]  A. Norton,et al.  Brief, high‐temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues , 1994, The Journal of pathology.

[53]  A. Harris,et al.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer , 1992, The Lancet.

[54]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[55]  L. Sobin,et al.  Histological Typing of Breast Tumors 1 , 1982 .

[56]  R. W. Scarff,et al.  Histological typing of breast tumors. , 1982, Tumori.